Get access

Mutations in ATP1A3 cause alternating hemiplegia of childhood

Authors

  • F Aminkeng

    Corresponding author
    • The Canadian Pharmacogenomic Network for Drug Safety (CPNDS), Center for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
    Search for more papers by this author

e-mail: folefac@cmmt.ubc.ca

Abstract

Heterozygous de novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.

Rosewich et al. (2012)

Lancet Neurology 11(9):764–773

Ancillary